drugset

drugset / Trial / NCT03009136

Efficacy and Safety of So-Cheong-Ryong-Tang on Perennial Allergic Rhinitis

NCT03009136 ↗

Phase 3 Unknown 154 enrolled Kyung Hee University Hospital at Gangdong DongGuk University · collab Kyung Hee University Hospital · collab Pusan National University Hospital · collab Semyung University Affiliated Oriental Medical Hospital · collab

RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of this study is to investigate the short and long term efficacy and the safety of SCRT treatment for PAR

Timeline

Start: 2016-12-31
Primary completion: 2018-12
Completion: 2018-12

Outcome

Results reported · no primary-endpoint met/missed verdict (typical of a dose-finding / safety study)

paper Pre-results. PMID 28963290 ↗

Publications

Kim MH, Ko Y, Ahn JH, Yun Y, Yun MN, Ko SG, Choi I. Efficacy and safety of So-Cheong-Ryong-Tang in treatment of perennial allergic rhinitis: study protocol for a double-blind, randomised, parallel-group, multicentre trial. BMJ Open. 2017 Sep 27;7(9):e016556. doi: 10.1136/bmjopen-2017-016556.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	So-Cheong-Ryong-Tang	Traditional medicine (herbal / TCM)	3 g	Oral

Indications